Table 2.
HR | 95% CI | P value | |
---|---|---|---|
Full population | |||
CYP2C19, additive | 1.29 | 1.04–1.59 | 0.019 |
Age, years | 1.01 | 1.00–1.02 | 0.206 |
Male sex | 0.93 | 0.74–1.18 | 0.561 |
Aspirin use | 0.92 | 0.73–1.16 | 0.483 |
PPI use | 1.02 | 0.77–1.36 | 0.887 |
Ischemic stroke subpopulation | |||
CYP2C19, additive | 2.23 | 1.17–4.24 | 0.015 |
Age, years | 1.01 | 0.97–1.05 | 0.653 |
Male sex | 0.66 | 0.30–1.43 | 0.287 |
Aspirin use | 0.25 | 0.03–1.95 | 0.186 |
PPI use | 2.12 | 0.83–5.38 | 0.114 |
CI, confidence interval; HR, hazard ratio; PPI, proton pump inhibitor.